reports hero background
Updated: Nov 20, 2026
MLTX Logo

MoonLake

NASDAQ:MLTX·Stock Analysis Report
Day Range
$10.73 - $11.31
Market Cap
938.73M
P/E Ratio
0.0000
Avg Value
$16.40
Year Range
$9.50 - $23.29
$11.07$0.04 (0.36%)
1
General Information
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases.

The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

2
MoonLake (MLTX) Stock Graph
3
How We Grade MoonLake (MLTX)

We grade stocks based on past performance, their future growth potential, intrinsic value, dividend history, and overall financial health.

The chart below shows how we grade MoonLake (MLTX) across the board compared to its closest peers.

4
Benzinga Edge Rankings

Benzinga Edge stock rankings give you four critical scores to help you identify the strongest and weakest stocks to buy and sell.

Momentum measures a stock's relative strength based on its price movement patterns and volatility over multiple timeframes, ranked as a percentile against other stocks.

Stock Score Locked: Want to See it?
Benzinga Edge Rankings give you vital metrics on any stock – anytime.
5
Peer Ratings

See how MoonLake compares to its peers in these key performance metrics from Benzinga Rankings.

Top Peers
Value
Quality
Growth
Momentum
Short
Medium
Long
AKTSAktis Oncology
N/A
N/A
N/A
N/A
IMTXImmatics
N/A
N/A
N/A
5.44
ODTXOdyssey Therapeutics
N/A
N/A
N/A
N/A
VSTMVerastem
N/A
N/A
N/A
83.09
Short: price trend over the last couple of months
Medium: price trend over the last couple of quarters
Long: price trend over the past year
Stock Score Locked: Want to See it?
Benzinga Edge Rankings give you vital metrics on any stock – anytime.
6
Past Performance
How has MoonLake (MLTX) performed over the past 5 years?

The two main factors that we consider when analyzing past performance is overall return and volatility

Using these two metrics, we can determine if this stock gave its investors enough return for the risk that they took on by owning it. This is measured by the sharpe ratio, which has been used as a primary measure of risk/reward trade-off for almost 60 years.

This ratio can be interpreted as the amount of return an investor has received for the amount of risk that they took on by owning the stock over that timeframe.

MoonLake (MLTX) sharpe ratio over the past 5 years is 0.0255 which is considered to be above average compared to the peer average of -0.2572


Benzinga